International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 7 minute read Pharma Industry News A single appeals court ruling puts gene therapy patent economics back in play for Regenxbio Inc. and Sarepta Therapeutics Inc. Regenxbio Inc. wins a key appeals court reversal against Sarepta Therapeutics Inc. Discover what this means for gene therapy IP and investors. byPallavi MadhirajuFebruary 22, 2026